Remove 2024 Remove Confidentiality Remove Invention Remove Patent
article thumbnail

Celanese v. ITC – Exploring the Crossroads of Trade Secrets and Patent Rights Post AIA

Trading Secrets

2024), a case that may reshape the dynamics between trade secrets and patent rights. The Core Issue at Hand This case centers around the America Invents Act (AIA) and whether a product’s prior sale by the patent applicant can disqualify the patenting of the method used to produce said product. v ITC, 22-1827 (Fed.

article thumbnail

Celanese v. ITC – Exploring the Crossroads of Trade Secrets and Patent Rights Post AIA

LexBlog IP

2024), a case that may reshape the dynamics between trade secrets and patent rights. The Core Issue at Hand This case centers around the America Invents Act (AIA) and whether a product’s prior sale by the patent applicant can disqualify the patenting of the method used to produce said product. Plot twist!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Celanese v. ITC – Exploring the Crossroads of Trade Secrets and Patent Rights Post AIA

LexBlog IP

2024), a case that may reshape the dynamics between trade secrets and patent rights. The Core Issue at Hand This case centers around the America Invents Act (AIA) and whether a product’s prior sale by the patent applicant can disqualify the patenting of the method used to produce said product. Plot twist!

article thumbnail

What’s in a Missing Name? Some Questions Around the Covaxin Patent Application

SpicyIP

The Exclusion of ICMR from the Patent Application Last weekend, a series of unusual developments regarding the Covaxin patent (Patent Application Number: 202041007559) generated significant buzz. Due to the confidentiality of the BBIL-ICMR agreement, which was not readily accessible, ICMR was unintentionally omitted.

article thumbnail

Patent Rules Published: A Quick Look 

SpicyIP

Image from here On March 15, the Patent (Amendment) Rules, 2024 were published in the Gazette of India, making crucial changes in the Indian patent regime. Article 12 of the IP Annex to the TEPA, wherein the parties can seek information on the working of the patent only once after at least three years. Article 11.7

article thumbnail

Some Concerns about the Amendment Process to Key Patent Levers: A “Captured” Patent Office?

SpicyIP

In light of the recent Patent (Amendment) Rules, 2024, we are pleased to bring this post by Prashant Reddy T., Image from here A ‘Captured’ Patent Office? Two of the provisions slated to be amended have a direct impact on the quality of patents granted by the Patent Office. Prashant Reddy T.

Patent 52
article thumbnail

SpicyIP Weekly Review (February 26- March 3)

SpicyIP

Controller Gen of Patents: The DHC’s Dilemma of Identifying the Method of Treatment under Section 3(i) of the Patent Act In the context of Section 3(i), the DHC recently clarified that a ‘method of treatment’ is distinct from a ‘method of producing a substance’ that can later be used in the treatment.